Introduction: MHC class II-restricted antigen presentation

By Miller J.   Sant A.J.  

Seminars in Immunology, Vol. 7, Iss. 6, 1995-12 ,pp. : 343-346

Academic Press

Access to resources Recommend Favorite

Identification of a MHC class-II restricted epitope in carcinoembryonic antigen

By Shen Lei   Schroers Roland   Hammer Juergen   Huang Xue   Chen Si-Yi  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 5, 2004-05 ,pp. : 391-403

Springer Publishing Company

Access to resources Recommend Favorite

Fc receptors for IgG and antigen presentation on MHC class I and class II molecules

By Amigorena S.   Bonnerot C.  

Seminars in Immunology, Vol. 11, Iss. 6, 1999-12 ,pp. : 385-390

Academic Press

Access to resources Recommend Favorite

MHC class II and CD80 tumor cell–based vaccines are potent activators of type 1 CD4⁺ T lymphocytes provided they do not coexpress invariant chain

By Ilkovitch Dan   Ostrand-Rosenberg Suzanne  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 6, 2004-06 ,pp. : 525-532

Springer Publishing Company

Access to resources Recommend Favorite

Intracellular organelles involved in antigen processing and the binding of peptides to class II MHC molecules

By Harding C.V.  

Seminars in Immunology, Vol. 7, Iss. 6, 1995-12 ,pp. : 355-360

Academic Press

Access to resources Recommend Favorite